Hologic Announces Board and Executive Compensation Changes

Ticker: HOLX · Form: 8-K · Filed: Sep 19, 2025 · CIK: 859737

Hologic INC 8-K Filing Summary
FieldDetail
CompanyHologic INC (HOLX)
Form Type8-K
Filed DateSep 19, 2025
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: governance, executive-compensation, board-changes

TL;DR

Hologic's board is shuffling, with a director out, a new one in, and exec pay adjustments.

AI Summary

Hologic, Inc. announced on September 18, 2025, changes related to its board of directors and executive compensation. Specifically, the company reported the departure of a director, the election of a new director, and adjustments to compensatory arrangements for certain officers. These changes are effective as of September 18, 2025.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.

Risk Assessment

Risk Level: low — This filing reports routine corporate governance changes and does not indicate significant financial distress or operational disruption.

Key Players & Entities

FAQ

What specific item information is being reported in this 8-K filing?

This 8-K filing reports on the Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, and Compensatory Arrangements of Certain Officers.

What is the exact date of the earliest event reported in this filing?

The date of the earliest event reported is September 18, 2025.

What is Hologic, Inc.'s state of incorporation?

Hologic, Inc. is incorporated in Delaware.

What is the principal executive office address for Hologic, Inc.?

The principal executive office address is 250 Campus Drive, Marlborough, Massachusetts 01752.

What is the telephone number for Hologic, Inc.?

The telephone number for Hologic, Inc. is (508) 263-2900.

Filing Stats: 428 words · 2 min read · ~1 pages · Grade level 10.8 · Accepted 2025-09-19 16:05:37

Filing Documents

02

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 18, 2025, Hologic, Inc. (the "Company") and Stephen P. MacMillan, the Company's Chairman, President and Chief Executive Officer, entered into an amendment to Mr. MacMillan's amended and restated employment agreement dated September 18, 2015, as amended, solely to extend the term of such agreement until such time as the agreement is otherwise terminated by the Company or Mr. MacMillan in accordance with its terms.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 19, 2025 HOLOGIC, INC. By: /s/ Anne M. Liddy Anne M. Liddy General Counsel

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing